SCHEMBL7968702

SCHEMBL7968702

O=C(Cl)c1ccnc(-c2ccccc2)n1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.47
SMO Q99835 2/20 0.44
COMT P21964 1/20 0.41
KMT2A Q03164 7/20 0.40
MEN1 O00255 5/20 0.40
XDH P47989 1/20 0.40
LMNA P02545 1/20 0.40
MAP4K4 O95819 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
MAPT P10636 2/20 0.39
HPGD P15428 1/20 0.39
HPGDS O60760 1/20 0.39
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL696116 0.85 XDH (0.50) HDAC6SMOCOMTKMT2AMEN1
Hydrochloric Acid SCHEMBL7968706 0.84 XDH (0.49) HDAC6SMOCOMTKMT2AMEN1
SCHEMBL2543831 0.82 HDAC6 (0.50) HDAC6SMOCOMTKMT2AMEN1
SCHEMBL29383595 0.82 HDAC6 (0.50) HDAC6SMOCOMTKMT2AMEN1
SCHEMBL21294995 0.80 POLB (0.60) HDAC6SMOKMT2AMEN1LMNA
SCHEMBL14741986 0.78 MAPT (0.48) HDAC6KMT2ALMNAMAPTHPGD
SCHEMBL27846472 0.78 CYP1A2 (0.47) KMT2AMEN1LMNANPC1RAB9A
Ammonia Solution, Strong SCHEMBL28126176 0.77 MAPT (0.47) HDAC6KMT2ALMNAMAPTHPGD
SCHEMBL27727106 0.76 HDAC6 (0.45) HDAC6SMOCOMTKMT2AMEN1
SCHEMBL27717163 0.75 KMO (0.53) XDHMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6281359-B1 PSYCHOLOGICAL DISORDERS NEUROGEN CORPORATION 2001-08-28 US disclosed
US-6221871-B1 TREATING SCHIZOPHRENIA, DEPRESSION OR PARKINSON'S DISEASE NEUROGEN CORPORATION 2001-04-24 US disclosed
US-5912350-A Certain aminomethyl biphenyl, aminomethyl phenyl pyridine and aminomethyl phenyl pyrimidine derivatives; novel dopamine receptor subtype selective ligands NEUROGEN CORPORATION (US) 1999-06-15 US disclosed
US-5677454-A DIAGNOSIS, THERAPY OF SCHIZOPHRENIA, DEPRESSION, PARKINSONISM NEUROGEN CORPORATION (US) 1997-10-14 US disclosed
EP-0793662-A1 AMINOMETHYL ARYL COMPOUNDS; DOPAMINE RECEPTOR SUBTYPE SELECTIVE LIGANDS NEUROGEN CORPORATION (US) 1997-09-10 EP disclosed
US-5594141-A ANTIPSYCHOTIC AND ANTIDEPRESSANT AGENTS; PARKINSON'S DISEASE NEUROGEN CORPORATION (US) 1997-01-14 US disclosed
WO-1996016058-A1 AMINOMETHYL ARYL COMPOUNDS; DOPAMINE RECEPTOR SUBTYPE SELECTIVE LIGANDS NEUROGEN CORPORATION (US) 1996-05-30 WO disclosed